DDrare: Database of Drug Development for Rare Diseases

Device: use of bioanalytical assay to monitor plasma levels of perhexiline (DrugBank: Perhexiline, MONITOR)

告示番号	疾患名（ページ内リンク）	臨床試験数
58	肥大型心筋症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02862600 (ClinicalTrials.gov)	August 1, 2016	8/8/2016	Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure	A Phase 2, Multi-Center, Open-Label, Ascending Dose Study on the Efficacy, Safety and Tolerability of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure With Preserved Left Ventricular Function	Cardiomyopathy, Hypertrophic;Cardiomyopathy, Hypertrophic, Familial	Drug: Perhexiline;Device: Use of bioanalytical assay to monitor plasma levels of perhexiline	Heart Metabolics Limited	NULL	Terminated	18 Years	N/A	All	35	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02862600
(ClinicalTrials.gov)

August 1, 2016

8/8/2016

Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure

A Phase 2, Multi-Center, Open-Label, Ascending Dose Study on the Efficacy, Safety and Tolerability of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure With Preserved Left Ventricular Function

Cardiomyopathy, Hypertrophic;Cardiomyopathy, Hypertrophic, Familial

Drug: Perhexiline;Device: Use of bioanalytical assay to monitor plasma levels of perhexiline

Heart Metabolics Limited

NULL

Terminated

18 Years

N/A

All

Phase 2

United States